Globeflex Capital L P Takes $709,000 Position in Lam Research Corporation $LRCX

Posted by Stanley Muller on Aug 26th, 2026

Globeflex Capital L P bought a new position in shares of Lam Research Corporation (NASDAQ:LRCX – Free Report) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 1,637 shares of the semiconductor company’s stock, valued at approximately $709,000.

A number of other institutional investors have also modified their holdings of the business. Kirtland Hills Capital Management LLC raised its position in Lam Research by 4.2% in the 2nd quarter. Kirtland Hills Capital Management LLC now owns 12,101 shares of the semiconductor company’s stock valued at $5,244,000 after purchasing an additional 488 shares during the last quarter. Compass Financial Management LLC acquired a new stake in Lam Research during the 2nd quarter worth $3,721,000. C M Bidwell & Associates Ltd. purchased a new position in Lam Research during the 2nd quarter worth $1,462,000. Ninepoint Partners LP purchased a new position in Lam Research during the 2nd quarter worth $2,049,000. Finally, Abacus FCF Advisors LLC acquired a new position in Lam Research in the second quarter valued at $19,513,000. 84.61% of the stock is owned by institutional investors and hedge funds.

Trending Headlines about Lam Research

Here are the key news stories impacting Lam Research this week:

Positive Sentiment: AI-driven growth outlook: Reports indicate Lam Research expects strong growth to extend into 2027 as artificial-intelligence spending supports demand for semiconductor manufacturing equipment. The company’s recent earnings also showed momentum, with revenue rising 30% year over year and EPS exceeding analyst expectations.
Positive Sentiment: Analyst remains bullish: Mizuho lowered its price target modestly from $370 to $365 but maintained an “outperform” rating, implying substantial upside from the referenced price. Wall Street coverage broadly remains supportive of Lam Research’s growth prospects. Benzinga
Positive Sentiment: Investment in research and development: Lam Research plans to invest more than $3 billion over five years to expand its global R&D laboratory network and increase experimentation capacity. The spending could strengthen its technology pipeline and competitive position as chipmakers invest in advanced manufacturing. Lam Research R&D update
Neutral Sentiment: Short-interest data offers no signal: Reported short interest was zero shares both periods, producing a zero-day short ratio. Because the data shows no measurable short position, it does not provide a meaningful indication of potential buying pressure or bearish sentiment.
Negative Sentiment: Sector-wide pressure: Semiconductor stocks declined ahead of NVIDIA’s earnings report, reflecting investor de-risking and sensitivity to AI-related expectations. Weakness across chip equipment and foundry shares could weigh on LRCX despite its company-specific growth outlook. Semiconductor stocks slide
Negative Sentiment: Valuation and target reduction: LRCX trades at a relatively elevated earnings multiple, while Mizuho’s target-price cut signals some caution about near-term upside even though its rating remains positive.

Lam Research Trading Up 1.4%

NASDAQ:LRCX opened at $314.66 on Wednesday. The stock has a fifty day moving average price of $334.80 and a two-hundred day moving average price of $287.73. The stock has a market capitalization of $393.74 billion, a price-to-earnings ratio of 54.63, a PEG ratio of 1.23 and a beta of 1.84. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.91 and a current ratio of 2.63. Lam Research Corporation has a 1 year low of $94.11 and a 1 year high of $438.50.

Lam Research (NASDAQ:LRCX – Get Free Report) last issued its earnings results on Wednesday, July 29th. The semiconductor company reported $1.82 EPS for the quarter, topping the consensus estimate of $1.69 by $0.13. Lam Research had a net margin of 31.27% and a return on equity of 67.60%. The company had revenue of $6.72 billion for the quarter, compared to analyst estimates of $6.66 billion. During the same period in the previous year, the firm earned $1.33 EPS. The business’s revenue was up 30.0% on a year-over-year basis. Lam Research has set its Q1 2027 guidance at 2.000-2.300 EPS. As a group, sell-side analysts anticipate that Lam Research Corporation will post 9.32 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of equities research analysts have recently commented on LRCX shares. Oppenheimer reaffirmed an “outperform” rating and issued a $400.00 target price (up from $330.00) on shares of Lam Research in a report on Monday, June 15th. Sanford C. Bernstein boosted their price target on Lam Research from $325.00 to $340.00 and gave the company an “outperform” rating in a research report on Thursday, May 21st. B. Riley Financial reduced their price objective on Lam Research from $385.00 to $350.00 and set a “buy” rating for the company in a research note on Thursday, July 30th. Bank of America increased their price objective on Lam Research from $330.00 to $480.00 and gave the stock a “buy” rating in a research report on Tuesday, June 23rd. Finally, Rothschild & Co Redburn lifted their target price on Lam Research from $305.00 to $420.00 and gave the company a “buy” rating in a research note on Wednesday, June 17th. One investment analyst has rated the stock with a Strong Buy rating, twenty-six have issued a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $357.31.

Get Our Latest Analysis on Lam Research

Insider Buying and Selling

In related news, Director Abhijit Y. Talwalkar sold 18,282 shares of the business’s stock in a transaction dated Monday, July 13th. The shares were sold at an average price of $335.00, for a total transaction of $6,124,470.00. Following the sale, the director owned 87,142 shares of the company’s stock, valued at approximately $29,192,570. The trade was a 17.34% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Neil J. Fernandes sold 7,659 shares of the stock in a transaction dated Monday, June 1st. The shares were sold at an average price of $309.60, for a total transaction of $2,371,226.40. Following the completion of the transaction, the senior vice president directly owned 58,470 shares of the company’s stock, valued at approximately $18,102,312. This trade represents a 11.58% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders have sold 80,441 shares of company stock valued at $27,614,296. Corporate insiders own 0.31% of the company’s stock.

Lam Research Profile

(Free Report)

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.